We are live on ! Find out more
TCM

Tygh Capital Management Portfolio holdings

AUM $782M
1-Year Est. Return 39.44%
This Fund
S&P 500
This Quarter Est. Return
+11.86%
1 Year Est. Return
+39.44%
3 Year Est. Return
+251.35%
5 Year Est. Return
+417.76%
10 Year Est. Return
–
AUM
$528M
AUM Growth
+$48.1M
Cap. Flow
+$7.21M
Cap. Flow %
1.37%
Top 10 Hldgs %
24.64%
Holding
106
New
27
Increased
32
Reduced
25
Closed
22

Top Buys

Rank Stock Value
1
CUB
Cubic Corporation
CUB
+$10.1M
2
VERX icon
Vertex
VERX
+$8.17M
3
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$7.48M
4
CACI icon
CACI
CACI
+$5.99M
5
MODV
ModivCare
MODV
+$5.82M

Top Sells

Rank Stock Value
1
STRA icon
Strategic Education
STRA
+$8.56M
2
CRL icon
Charles River Laboratories
CRL
+$5.86M
3
NATI
National Instruments Corp
NATI
+$5.66M
4
HCSG icon
Healthcare Services Group
HCSG
+$5.52M
5
KAI icon
Kadant
KAI
+$5.35M

Sector Composition

Rank Sector Weight
1 Healthcare 28.7%
2 Technology 26.53%
3 Industrials 17.04%
4 Consumer Discretionary 8.67%
5 Financials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KNSL icon
1
Kinsale Capital Group
KNSL
$7.95B
$16.7M 3.17%
87,815
-8,897
-9% -$1.64M
EBS icon
2
Emergent Biosolutions
EBS
$375M
$13.5M 2.56%
130,526
-12,870
-9% -$1.39M
PRAH
3
DELISTED
PRA Health Sciences, Inc.
PRAH
$13.4M 2.54%
132,293
+50,635
+62% +$5.16M
CVCO icon
4
Cavco Industries
CVCO
$4.39B
$13.4M 2.53%
74,093
+7,818
+12% +$1.49M
NTRA icon
5
Natera
NTRA
$37.5B
$13.3M 2.52%
184,254
-28,834
-14% -$1.64M
CUB
6
DELISTED
Cubic Corporation
CUB
$12.5M 2.37%
+214,815
New +$10.1M
RGEN icon
7
Repligen
RGEN
$7.44B
$12.2M 2.3%
82,367
-128
-0.2% -$18.3K
BIO icon
8
Bio-Rad Laboratories Class A
BIO
$8.42B
$11.9M 2.25%
23,013
-1,821
-7% -$922K
WNS
9
DELISTED
WNS Holdings
WNS
$11.7M 2.21%
182,533
+3,293
+2% +$208K
G icon
10
Genpact
G
$5.3B
$11.6M 2.19%
297,073
+14,799
+5% +$583K
CACI icon
11
CACI
CACI
$10.8B
$10.2M 1.93%
47,789
+27,718
+138% +$5.99M
LHCG
12
DELISTED
LHC Group LLC
LHCG
$9.97M 1.89%
46,914
+847
+2% +$167K
PWR icon
13
Quanta Services
PWR
$93.9B
$9.66M 1.83%
182,693
+3,285
+2% +$153K
TFII icon
14
TFI International
TFII
$12.4B
$9.48M 1.8%
226,700
+20,325
+10% +$856K
KTOS icon
15
Kratos Defense & Security Solutions
KTOS
$8.88B
$9.4M 1.78%
487,796
+145,408
+42% +$2.69M
NICE icon
16
Nice
NICE
$5.29B
$9.21M 1.75%
40,581
+737
+2% +$157K
SILK
17
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$9.21M 1.75%
+137,010
New +$7.48M
LMAT icon
18
LeMaitre Vascular
LMAT
$2.18B
$8.92M 1.69%
274,157
+94,489
+53% +$2.84M
XBI icon
19
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$8.9M 1.69%
79,879
+1,626
+2% +$182K
WSC icon
20
WillScot Mobile Mini Holdings
WSC
$4.8B
$8.89M 1.69%
533,298
-160,138
-23% -$2.56M
EFOR
21
Everforth Inc
EFOR
$845M
$8.73M 1.66%
137,423
-42,683
-24% -$2.94M
PCRX icon
22
Pacira BioSciences
PCRX
$1.02B
$8.38M 1.59%
139,335
+62,160
+81% +$3.61M
LGND icon
23
Ligand Pharmaceuticals
LGND
$6.02B
$8.29M 1.57%
139,453
-61,084
-30% -$4.17M
CRL icon
24
Charles River Laboratories
CRL
$10.9B
$7.91M 1.5%
34,910
-28,248
-45% -$5.86M
ONTO icon
25
Onto Innovation
ONTO
$13.6B
$7.9M 1.5%
265,301
-12,277
-4% -$407K
1
2 3 4 5

Similar funds

IVP
IA Venture Partners New York $785M AUM
FMBTD
First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return
EHPM
Emery Howard Portfolio Management Burlingame, California $773M AUM 18.85% 1-Year Est. Return
VMV
Venrock Management V Palo Alto, California $719M AUM
SIM
SCGF III Management Menlo Park, California $673M AUM
HAM
Hillcrest Asset Management Plano, Texas $656M AUM 31.12% 1-Year Est. Return
VIMU
Veritas Investment Management (UK) London, United Kingdom $648M AUM 36.52% 1-Year Est. Return
AC
Alley Company Lake Forest, Illinois $631M AUM 24.9% 1-Year Est. Return

Tygh Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Tygh Capital Management held 106 positions worth $528M, up 10% from $480M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tygh Capital Management's Q3 2020 filing shows 27 new, 32 increased, 25 reduced and 22 closed positions. Its largest new stake was Cubic Corporation: 214,815 shares worth $12.5M. The largest sale was Strategic Education, an estimated $8.56M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.

  • Tygh Capital Management's largest Q3 2020 buy was Cubic Corporation: 214,815 shares worth $12.5M.
  • Tygh Capital Management added most to CACI in Q3 2020, an estimated $5.99M increase.
  • Tygh Capital Management's biggest Q3 2020 reduction was Charles River Laboratories, cutting an estimated $5.86M.
  • Tygh Capital Management fully exited Strategic Education in Q3 2020, selling an estimated $8.56M.
  • Tygh Capital Management's ten largest holdings make up 25% of its $528M portfolio in Q3 2020.
  • Tygh Capital Management opened 27 new positions and closed 22 in Q3 2020.
  • Tygh Capital Management's portfolio value rose 10% quarter-over-quarter to $528M.

Based on Tygh Capital Management's 13F filing for Q3 2020, filed 5 Nov 2020.